![](/images/graphics-bg.png)
Cardiovascular risk assessement in osteoporotic patients using osteoprotegerin as a reliable predictive biochemical marker
Joint Authors
Rashid, Nura W.
Taresh, Ooroba J.
Source
مجلة ابن الهيثم للعلوم الصرفة و التطبيقية
Publisher
University of Baghdad College of Education for Pure Science / Ibn al-Haitham
Publication Date
2017-12-31
Country of Publication
Iraq
No. of Pages
9
Main Subjects
English Abstract
Some studies indicated a relationship between increased serum levels of osteoprotegerin with arterial calcification and as a result, it leads to the risk of cardiovascular disease.
In our study group we selected patients with osteoporosis, with similar age and body mass index for the assessment of the relationship between cardiovascular disease and osteoprotegerin serum level.
We took into account the analysis of correlation and association between the presence of distinct patterns of atherosclerosis and associated diseases like high blood pressure, diabetes mellitus, low HDL cholesterol, increased LDL cholesterol, increased triglycerides and was the case of presence of any type of dyslipidemia, in case of pre-existent treatment.
Objective of study was the assessment of osteoprotegerin value as predictive marker for cardiovascular and metabolic risk in osteoporotic patients.
Our results showed significant correlations of parathyroid hormone, osteocalcin and biochemical markers of bone with glucose metabolism and lipid were found in our research, maintaining crosstalk between calcium and biochemical markers of bone and cardiovascular risk.
The serum level of Osteoprotegerin has been shown to have a large predictive value for the metabolic syndrome as a cardiovascular risk standard in patients with osteoporosis.
The osteoprotegerin serum levels were increased in the patients with metabolic syndrome as a protective response facing the atherosclerotic lesions.
Data Type
Conference Papers
Record ID
BIM-851587
American Psychological Association (APA)
Rashid, Nura W.& Taresh, Ooroba J.. 2017-12-31. Cardiovascular risk assessement in osteoporotic patients using osteoprotegerin as a reliable predictive biochemical marker. International Conference on Biology, Chemistry, Computer Science, Mathematics, and Physics, will take place (2017 : Ibn Al Haitham University of Baghdad, Iraq). . Special issue (2017), pp.248-256.Baghdad Iraq : University of Baghdad College of Education for Pure Science / Ibn al-Haitham.
https://search.emarefa.net/detail/BIM-851587
Modern Language Association (MLA)
Rashid, Nura W.& Taresh, Ooroba J.. Cardiovascular risk assessement in osteoporotic patients using osteoprotegerin as a reliable predictive biochemical marker. . Baghdad Iraq : University of Baghdad College of Education for Pure Science / Ibn al-Haitham. 2017-12-31.
https://search.emarefa.net/detail/BIM-851587
American Medical Association (AMA)
Rashid, Nura W.& Taresh, Ooroba J.. Cardiovascular risk assessement in osteoporotic patients using osteoprotegerin as a reliable predictive biochemical marker. . International Conference on Biology, Chemistry, Computer Science, Mathematics, and Physics, will take place (2017 : Ibn Al Haitham University of Baghdad, Iraq).
https://search.emarefa.net/detail/BIM-851587